Specialty Pharmacy

Researchers examine interventions that may improve adherence in chronic viral hepatitis care.

CDC now recommends a 2-dose series of the HPV vaccination in children 11 to 12 years of age.

Top news of the week in oncology and cancer drug development.

New data indicates men of African American and Hispanic descent are less likely to undergo therapy for prostate cancer compared with Caucasian men.

A small proportion of HIV-infected children do not develop AIDS by controlling the virus in a different way than infected adults who remain disease-free.

Entyvio is a humanized monoclonal antibody for patients with moderate-to-severe ulcerative colitis and Crohn’s disease.

Targeting the uracil-DNA glycosylase enzyme may help treat certain types of non-Hodgkin’s lymphoma.

Top news of the day from across the health care landscape.

Top articles of the week on Specialty Pharmacy Times.

Efficacy and safety data shows encouraging results for rucaparib in BRCA-mutation ovarian cancer.

Broad-spectrum HIV-targeting monoclonal antibodies may lead to a cure for HIV in the future.

Recent findings suggest the implementation of intervention programs that target young males of a lower socio-economic status, non-cancer and cancer survivors, and cervical cancer survivors to help reduce the consumption of sugary drinks and added sugar.

Treating financial toxicity in cancer patients similarly to other side effects could improve outcomes.

Lartruvo with doxorubicin significantly improves overall survival in patients with soft tissue sarcoma.

Patients with Crohn’s disease achieve highest clinical response and remission rates during an early study.

Relapsed metastatic head-and-neck cancer patients who received nivolumab experienced a reduction in symptoms.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses lessons the specialty industry learned from the impact of high cost drug launches for hepatitis C and high cholesterol.

Top news of the day from across the health care landscape.

Evidence-based treatment for depression and adherence counseling could boost HIV treatment.

An update of distribution and circulation of HCV genotypes could help reduce disease burden.

The mail-order pharmacy marketplace has significantly changed since the year 2000.

Compared with standard-of-care for patients with inflammatory bowel disease (IBD), a new study found that medication therapy management (MTM) increased adherence more than 30%.

Major pathological tumor regression was experienced by 40% of patients receiving neoadjuvant immunotherapy before resection.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses the relationship between limited distribution networks and specialty pharmacy.

A diagnostic blood test could diagnose patients in early stages of non-alcoholic fatty liver disease.

Top news of the day from across the health care landscape.

HIV compromises the immune system, making patients more susceptible to tuberculosis.

Developing industry connections is crucial for aspiring pharmacists.

Tecentriq is the first anti-PDL1 cancer immunotherapy approved for metastatic non-small cell lung cancer.

Adalimumab also found to be effective in treating non-infectious uveitis.